Get an Inside Look at the CDDF Multi-Stakeholder Discussion on Innovative Oncology Trial Design
Watch the interviews with participants from the CDDF Multi-stakeholder Workshop on Innovative Oncology Trial Design (18-19 September 2023, Amsterdam) and gain valuable perspectives from diverse stakeholders in cancer drug development. Collaboration is key to...
CDDF’s New Publication: White Paper – “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”
The CDDF is delighted to announce that the White Paper, “Empowering Involvement and Engagement of Patients with Cancer in Oncology Drug Development”, has been published in October 2023. It has been prepared by Prof. Mark Lawler on behalf of the Cancer Drug Development...
Key Takeaways from the CDDF Webinar on Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 (28 September 2023)
The Cancer Drug Development Forum (CDDF) held a live webinar on “Perspectives on the new EU Health Technology Assessment HTA Regulation 2021/2282 “ on Thursday 28 September 2023. In this webinar, Marcus Guardian and Julie Spony provided an overview of the topic...
Executive Summary of the Workshop on “Innovative Oncology Trial Designs” (September 2023, Amsterdam)
The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Innovative Oncology Trial Designs.” The multi-stakeholder workshop took place on 18 – 19 September 2023 in Amsterdam, NL. The gathering brought together the...